Stimulation of nonspecific resistance by thymopentin and its analogs against leishmania donovani infection in hamsters

Peptides

Volumn 20, Issue 11, 1999, Pages 1381-1383

  Sharma Anuradha, P ^a   Rohatgi, A ^a   Haq, W ^a   Mathur, K B ^a   Katiyar, J C ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Hamsters; L. donovani; Thymopentin

Indexed keywords

THYMOPENTIN; THYMOPENTIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HAMSTER; HOST RESISTANCE; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; LEISHMANIA DONOVANI; LEISHMANIASIS; THYMOPENTIN;

EID: 0032795065     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00146-1     Document Type: Article

References (10)

1. Audhya T., Scheid M.P., Goldstein G. Contrasting biological activity of thymopentin and spelenin, two closely related polypeptide products of thymus and spleen. Proc Natl Acad Sci USA. 81:1984;2847-2849.
2. Cordero O.J., Maurer H.R., Nogueira M. Novel approaches to immunotherapy using thymic peptides. Immunol Today. 18:1997;10-13.
3. Diezel W., Weber H.A., Maciejewski J., Volk H.-D. The effect splenopentin (DA SP-5) on in vitro myelopoiesis and on AZT-induced bone marrow toxicity. Int J Immunopharmacol. 15:1993;269-273.
4. Georgiev V.S. Immunomodulating peptides of natural and synthetic origin. Med Res Rev. 11:1991;81-119.
5. Goldstein AL. In combination therapies 2. Biological response modifiers in the treatment of cancer and infectious diseases. In: Goldstein AL, Garaci E, editors. New York: Plenum Press, 1993:39-48.
6. Lederer E. Synthetic immunostimulants derived from bacterial cell wall. J Med Chem 1980;23:891-25.
7. Rastogi A., Singh V.K., Biswas S., Haq W., Mathur K.B., Agarwal S.S. Augmentation of human natural killer cells by splenopentin analogs. FEBS Lett. 317:1993;93-95.
8. Singh V.K., Biswas S., Mathur K.B., Haq W., Garg S.K., Agarwal S.S. Thymopentin and splenopentin as Immunomodulators Current status . Immunologic Res. 16:1997;439-462.
9. Sharma P., Anuradha, Sharan R., Haq W., Kundu B., Katiyar J.C., Mathur K.B. Stimulation of non-specific resistance by human casein fragment (54-59) and its synthetic analogs against Leishmania donovani infection. Protein Peptide Lett. 3:1996;261-266.
10. Stiefel T, Porcher H. Preparation of splenopentin analogs as drugs. Ger Offen DE 4,001,207: 1992. [Chem Abstr 116: 106816z,1992].